Kenya is the latest country to assert that it will not let international patent protection restrict access to life-saving medicines, including HIV drugs, according to a report from the U.N. Integrated Regional Information Networks (IRIN).
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has issued a public consultation on whether naproxen 250-mg tablets should be made available OTC for treating primary dysmenorrhoea, or period pain, for women ages 15 to 50.
A weeklong meeting of African Union (AU) health ministers is under way in Johannesburg, South Africa, and activists have expressed concern that commitments on HIV/AIDS made at meetings last year are missing from the agenda, the U.N. Integrated Regional Information Networks (IRIN) reports.
Gilead Sciences is planning to invest 60 million euros in developing a new world-class pharmaceutical plant in Dublin, Ireland, the country's Minister for Enterprise, Trade and Employment Micheál Martin announced.
response to the U.S government's request for a World Trade Organization panel to investigate intellectual property rights enforcement in China, the Pharmaceutical Research and Manufacturers of America (PhRMA) issued a statement saying the move shows the U.S. government's commitment to fighting counterfeit drugs.